Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study

References

• DMParkin, FBray, IFerlay, PPisani. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
   PubMed Web of Science ®Google Scholar
• JMLlovet, ABurroughs, JBruix. Hepatocellular carcinoma. Lancet 2003;362:1907–17.
   PubMed Web of Science ®Google Scholar
• MIShariff, UCox, AIGomaa, SAKhan, WGedroyc, SDTaylor-Robinson. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009;3:353–67.
   PubMedGoogle Scholar
• HBEl Serag, ACMason. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745–50.
   PubMed Web of Science ®Google Scholar
• SDTaylor-Robinson, GRFoster, SAora, SHargreaves, HCThomas. Increase in primary liver cancer in the UK. 1979-94. Lancet 1997;350:1142–3.
   PubMed Web of Science ®Google Scholar
• MLaw, SKRoberts, GJDore, JKaldor. Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust 2000;173:403–5.
   PubMedGoogle Scholar
• KAMcGlynn, LTsao, AWHsing, SSDevesa, JFFraumeniJr. International trends of primary liver cancer. Int J Cancer 2001;94:290–6.
   PubMed Web of Science ®Google Scholar
• JBruix, JMLlovet. Major advancements in hepatocellular carcinoma. Lancet 2009;373:614–16.
   PubMed Web of Science ®Google Scholar
• WKemp, SNguyen, MJBailey, SPianko, SKRoberts. Survival in hepatocellular carcinoma: impact of screening and aetiology of liver disease. J Gastro Hepatol 2005;20:873–81.
   PubMed Web of Science ®Google Scholar
• IIkai, MKudo, SArii, MOmata, MKojiro, MSakamato, et al. Report of the 18th follow up survey of primary liver cancer in Japan. Hepatol Res 2010;40:1043–59.
   PubMed Web of Science ®Google Scholar
• JBruix, MSherman; Practice guidelines committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208–36.
   PubMed Web of Science ®Google Scholar
• JMLlovet, MDucreux, RLencioni, AMDi Bisceglie, PRGalle, JFDufour, et al. EASL–EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908–43.
   PubMed Web of Science ®Google Scholar
• GMarin-Hargreaves, DAzoulay, HBismuth. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 2003;47:13–27.
   PubMed Web of Science ®Google Scholar
• FBorie, AMBouvier, AHerrero, JFaivre, GLaunoy, PODelafosse, et al. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol 2008;98:505–9.
   PubMed Web of Science ®Google Scholar
• TLivraghi, FMeloni, MDi Stasi, ERolle, ISolbiati, CTinelli, et al. Sustained complete response and complication rates, after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008;47:82–9.
   PubMed Web of Science ®Google Scholar
• GN’Kontchou, AMahamoudi, AMounir, NGanne-Carrie, VGrando, ECoderc, et al. Radiofrequency ablation of hepatocellular carcinoma: long term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009;50:1475–83.
   PubMed Web of Science ®Google Scholar
• RLencioni, HAllgaler, DCloni, MOlschewski, PDeibert, LCrocetti, et al. Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235–40.
   PubMed Web of Science ®Google Scholar
• SShiina, TTeratani, SObi, SSato, RTateishi, TFujishima, et al. A Randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122–30.
   PubMed Web of Science ®Google Scholar
• YCho, JKim, MKim, JHan. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009;49:453–70.
   PubMed Web of Science ®Google Scholar
• SMLin, CJLin, CCLin, CWHsu, YCChen. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151–6.
   PubMed Web of Science ®Google Scholar
• JHuang, LYan, ZCheng, HWu, JWang, YXu, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010;252:903–12.
   PubMed Web of Science ®Google Scholar
• MSChen, JQLi, YZheng, RPGuo, HHLiang, YQZhang, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321328.
   Google Scholar
• KFeng, JYan, XLi, FXia, KMa, SWang, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 2012;57:794–802.
   PubMed Web of Science ®Google Scholar
• SArii, YYamaoka, SFutagawa, KInoue, KKobayashi, MKojiro, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000;32:1224–9.
   PubMed Web of Science ®Google Scholar
• MVivarelli, AGuglielmi, ARuzzenente, ACucchetti, RBellusci, CCordiano, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004;240:102–7.
   PubMed Web of Science ®Google Scholar
• SNHong, SYLee, MSChoi, JHLee, KCKoh, SWPaik, et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005;39:247–52.
   PubMed Web of Science ®Google Scholar
• AGuglielmi, ARuzzenente, AValdegamberi, SPachera, TCampagnaro, MD’Onofrio, et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008;12:192–8.
   PubMed Web of Science ®Google Scholar
• AHiraoka, NHoriike, YYamashita, YKoizumi, KDoi, YYamamoto, et al. Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 2008;55:2171–4.
   PubMedGoogle Scholar
• SUeno, MSakoda, FKubo, KHiwatashi, TTateno, YBaba, et al. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 2009;16:359–66.
   PubMedGoogle Scholar
• JHuang, RHernandez-Alejandro, KPCroome, LYan, HWu, ZChen, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics – a retrospective study of 1,061 cases. J Gastrointest Surg 2011;15:311–20.
   PubMedGoogle Scholar
• WKYun, MSChoi, DChoi, HCRhim, JWJoh, KHKim, et al. Superior longterm outcomes after surgery in Child-Pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int 2011;5:722–9.
   PubMedGoogle Scholar
• HHHung, YYChiou, CYHsia, CWSu, YHChou, JHChiang, et al. Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol 2011;9:79–86.
   PubMed Web of Science ®Google Scholar
• JHWang, CCWang, CHHung, CLChen, SNLu. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 2012;56:412–18.
   PubMed Web of Science ®Google Scholar
• ZWPeng, XJLin, YJZhang, HHLiang, RPGuo, MShi, et al. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 2012;262:1022–33.
   PubMed Web of Science ®Google Scholar
• MPompili, ASaviano, Nde Mattheis, ACucchetti, FArdito, BFederico, et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J Hepatol 2013;59:89–97.
   PubMed Web of Science ®Google Scholar
• YZhou, YZhao, BLi, DXu, ZYin, FXie, et al. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 2010;10:78.
   PubMed Web of Science ®Google Scholar
• LLi, JZhang, XLiu, XLi, BJiao, TKang. Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: a metaanalysis. J Gastroenterol Hepatol 2012;27:51–8.
   PubMed Web of Science ®Google Scholar
• YKCho, JKKim, WTKim, JWChung. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 2010;51:1284–90.
   PubMed Web of Science ®Google Scholar
• Deloitte Access Economics. The economic cost and health burden of liver diseases in Australia. GESA 2013.
   Google Scholar
• TTakayama, MMakuuchi, KHasegawa. Single HCC smaller than 2 cm: surgery or ablation?: surgeon’s perspective. J Hepatobiliary Pancreat Sci 2010;17:422–4.
   PubMed Web of Science ®Google Scholar
• ARuzzenente, AGuglielmi, MSandri, TCampagnaro, AValdegamberi, SConci, et al. Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. J Gastrointest Surg 2012;16:301–11.
   PubMed Web of Science ®Google Scholar
• W-YKao, Y-YChiou, H-HHung, Y-HChou, C-WSu, J-CWi, et al. Risk factors for long term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index. Eur J Gastroenterol Hepatol 2011;23:528–36.
   PubMed Web of Science ®Google Scholar
• W-HLi, K-WMa, MCheng, K-HChui, P-TChan, W-HChu, et al. Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients. ANZ J Surg 2010;80:714–21.
   PubMedGoogle Scholar
• SShiina, RTateishi, TArano, KUchino, KEnooku, HNakagawa, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012;107:569–77.
   PubMed Web of Science ®Google Scholar